Ambys
is a California-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of liver diseases... Read moreAmbys
is a California-based biotechnology company that develops and commercializes cell and gene therapies for the treatment of liver diseases... Read more
2018
PrivateIndependent Company
News
Feb 23, 2023
EIN Presswire
Press Release: Ambys : Cytotheryx, Inc. Announces Acquisition of Ambys Medicines, Inc. Intellectual Property Assets
Feb 01, 2023
Endpoints News
Ambys: 'Moonshot' at liver cell therapy biotech Ambys Medicines comes to an end
Jun 27, 2022
Business Wire
Press Release: Ambys : Ambys Medicines Announces Formation of Clinical and Scientific Advisory Boards with Leading Liver Disease and Cell and Gene Therapy Experts
Jun 09, 2022
Business Wire
Press Release: Ambys : Ambys Medicines to Present Data from Universal Human Hepatocyte Program at the 2022 ISSCR Annual Meeting
May 18, 2022
FirstWord Pharma
Ambys: Ambys Medicines Presents New Data Further Validating its Novel Liver Cell Replacement Therapy Platform at the ASGCT Annual Meeting
May 09, 2022
FirstWord Pharma
Ambys: Ambys Medicines to Present New Data on Liver Cell Replacement Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Apr 20, 2022
FirstWord Pharma
Ambys: Ambys Medicines Expands Leadership Team with Key Appointments in Human Resources and Finance Functions
Dec 30, 2021
Silicon Valley Daily
Ambys: Ambys Medicines Completes $47 Million Series A Extension
Dec 22, 2021
Pharmaceutical Business Review
Ambys: Ambys raises funding to expand liver cell therapy production capabilities
Dec 21, 2021
Endpoints News
Ambys: Third Rock's Ambys closes a megaround with the clinic still a ways off for its regenerative cells for liver disease
Ambys Competitors
1
2
3
4
5
6
7
8
9
10